Signed in · PRO

Guidance history, every release

FMC Corporation (FMC) · 8 releases, Oct 29, 2024 to Jul 29, 2026 · rows are metrics, columns are releases

Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing

Metric	Oct 29, 2024 FY24 Q3	Feb 4, 2025 FY24 Q4	Apr 30, 2025 FY25 Q1	Jul 30, 2025 FY25 Q2	Oct 29, 2025 FY25 Q3	Feb 4, 2026 FY25 Q4	Apr 29, 2026 FY26 Q1	Jul 29, 2026 FY26 Q2
For FY2026
Growth at midpoint vs. 2025 (Revenue Excl. India)	—	—	—	—	—	—	—	New“(7)%”
Growth at midpoint vs. 2025 (Revenue Excl. India)	—	—	—	—	—	—	—	New“(9)%”
Growth at midpoint vs. 2025 (Revenue Excl. India)	—	—	—	—	—	—	—	New“4%”
Growth at midpoint vs. 2025 (Revenue)	—	—	—	—	—	New“-5%”	—	—
Revenue	—	—	—	—	—	—	—	New“$3.50 billion to $3.70 billion”
Revenue	—	—	—	—	—	—	New“$850 million to $900 million”	—
Revenue	—	—	—	—	—	New“between $725 million and $775 million”	—	—
Revenue	—	—	—	—	—	New“$3.60 billion to $3.80 billion”	—	—
Revenue (excl. India)	—	—	—	—	—	—	New“$3.60 billion to $3.80 billion”	—
Revenue Excl. India	—	—	—	—	—	—	—	New“$3.50 billion to $3.70 billion”
Revenue Excl. India	—	—	—	—	—	—	—	New“$840 million to $900 million”
Revenue Excl. India	—	—	—	—	—	—	—	New“$1.06 billion to $1.20 billion”
Revenue Excl. India	—	—	—	—	—	—	New“$1.61 billion to $1.66 billion”	—
Revenue Excl. India	—	—	—	—	—	—	New“$1.99 billion to $2.14 billion”	—
Revenue Excl. India	—	—	—	—	—	—	New“$850 million to $900 million”	—
Revenue Excl. India Growth at midpoint vs. 2025	—	—	—	—	—	—	New“(11)%”	—
Revenue Excl. India Growth at midpoint vs. 2025	—	—	—	—	—	—	New“(17)%”	—
Revenue excluding India	—	—	—	—	—	—	—	New“expected to be in the range of $840 million to $900 million”
Revenue excluding India	—	—	—	—	—	—	—	New“expected to be in the range of $1.06 billion to $1.20 billion”
Revenue excluding India	—	—	—	—	—	New“$3.60 billion to $3.80 billion”	—	—
Revenue excluding India	—	—	—	—	—	New“$725 million to $775million”	—	—
Revenue excluding India (full-year)	—	—	—	—	—	—	—	New“a range of $3.50 billion to $3.70 billion”
Adjusted earnings per diluted share	—	—	—	—	—	—	—	New“$0.05 to $0.13”
Adjusted earnings per diluted share	—	—	—	—	—	—	—	New“$1.09 to $1.33”
Adjusted earnings per diluted share	—	—	—	—	—	—	—	New“in the range of $0.05 to $0.13”
Adjusted earnings per diluted share	—	—	—	—	—	—	—	New“in the range of $1.09 to $1.33”
Adjusted earnings per diluted share (full-year)	—	—	—	—	—	—	—	New“a range of $1.19 to $1.49”
Adjusted EBITDA	—	—	—	—	—	—	—	New“$120 million to $140 million”
Adjusted EBITDA	—	—	—	—	—	—	—	New“$275 million to $315 million”
Adjusted EBITDA	—	—	—	—	—	—	—	New“forecasted to be in the range of $120 million to $140 million”
Adjusted EBITDA	—	—	—	—	—	—	—	New“forecasted to be in the range of $275 million to $315 million”
Adjusted EBITDA	—	—	—	—	—	New“$670 million to $730 million”	Reiterated“$670 million to $730 million”	Lowered“$395 million to $455 million”
Adjusted EBITDA	—	—	—	—	—	—	New“$130 million to $150 million”	—
Adjusted EBITDA	—	—	—	—	—	—	New“$202 million to $222 million”	—
Adjusted EBITDA	—	—	—	—	—	—	New“$468 million to $508 million”	—
Adjusted EBITDA	—	—	—	—	—	New“between $45 million and $55 million”	—	—
Adjusted EBITDA (full-year)	—	—	—	—	—	—	—	New“a range of $620 million to $680 million”
Adjusted EBITDA Growth at midpoint vs. 2025	—	—	—	—	—	—	New“(17)%”	—
Adjusted EBITDA Growth at midpoint vs. 2025	—	—	—	—	—	—	New“(32)%”	—
Adjusted EPS	—	—	—	—	—	New“$1.63 to $1.89”	—	Lowered“$1.19 to $1.49”
Adjusted EPS	—	—	—	—	—	—	—	New“$0.05 to $0.13”
Adjusted EPS	—	—	—	—	—	—	—	New“$1.09 to $1.33”
Adjusted EPS	—	—	—	—	—	—	New“$0.16 to $0.26”	—
Adjusted EPS	—	—	—	—	—	New“negative $0.44 to negative $0.32”	—	—
Adjusted EPS Growth at midpoint vs. 2025	—	—	—	—	—	—	New“(102)%”	—
Adjusted EPS Growth at midpoint vs. 2025	—	—	—	—	—	—	New“(70)%”	—
Adjusted EPS^	—	—	—	—	—	—	New“$(0.07) to $0.03”	—
Adjusted EPS^	—	—	—	—	—	—	New“$1.70 to $1.86”	—
Diluted shares assumed for EPS estimates	—	—	—	—	—	—	—	New“125.9 million diluted shares”
EPS (Adjusted earnings per diluted share)	—	—	—	—	—	—	New“$1.63 to $1.89”	—
Growth at midpoint vs. 2025 (Adjusted EPS)	—	—	—	—	—	New“$(1.20)”	—	—
Growth at midpoint vs. 2025 (Adjusted EPS)	—	—	—	—	—	New“$(0.56)”	—	—
Second-half Adjusted EBITDA	—	—	—	—	—	—	New“decrease 6 percent”	—
Second-half Adjusted EPS	—	—	—	—	—	—	New“decline 15 percent”	—
Additional tariff charges	—	—	—	—	—	New“approximately $20 million”	—	—
Debt paydown	—	—	—	—	—	New“$1 billion”	—	—
Debt reduction	—	—	—	—	—	New“$1 billion”	Reiterated“approximately $1 billion”	—
Debt-reduction proceeds target	—	—	—	—	—	—	—	New“approximately $1 billion of proceeds”
Free cash flow	—	—	—	—	—	New“negative $65 million to $65 million dollars”	Reiterated“negative $65 million to $65 million dollars”	—
Free cash flow (full-year)	—	—	—	—	—	—	—	New“increased to a range of $75 million to $225 million”
Growth at midpoint vs. 2025	—	—	—	—	—	—	—	New“(45)%”
Growth at midpoint vs. 2025	—	—	—	—	—	—	—	New“4%”
Growth at midpoint vs. 2025*	—	—	—	—	—	—	New“(102)%”	—
Growth at midpoint vs. 2025*	—	—	—	—	—	—	New“(15)%”	—
India headwind	—	—	—	—	—	—	New“2 percent headwind”	—
India headwind (full-year outlook)	—	—	—	—	—	—	—	New“a 2 percent headwind”
Price	—	—	—	—	—	—	New“lower by mid-single digits”	—
Price	—	—	—	—	—	—	New“decline mid-single digits”	—
Price (full-year outlook)	—	—	—	—	—	—	—	New“expected to be lower by mid-to-high single digits”
Sales of new active ingredients	—	—	—	—	—	New“between $300 million and $400 million”	Reiterated“between $300 million and $400 million”	—
Second-half sales	—	—	—	—	—	—	New“increase of 1 percent”	—
Volume	—	—	—	—	—	—	—	New“expected to be lower”
Volume	—	—	—	—	—	—	—	New“expected to show healthy growth”
Volume (excluding India)	—	—	—	—	—	—	New“up modestly”	—
Volume excluding India (full-year outlook)	—	—	—	—	—	—	—	New“expected to be in line with prior year”
For FY2025
Revenue	—	—	New“$2.42 billion to $2.46 billion”	—	Raised“$3.92 billion to $4.02 billion”	—	—	—
Revenue	—	—	—	New“$1.24 billion to $1.34 billion”	Lowered“$1.12 billion to $1.22 billion”	—	—	—
Revenue	—	—	—	New“$2.24 billion to $2.44 billion”	—	—	—	—
Revenue	—	—	New“$1.73 billion to $1.89 billion”	—	—	—	—	—
Revenue	—	New“$4.15 billion to $4.35 billion”	—	—	—	—	—	—
Revenue	—	New“$750 million to $800 million”	—	—	—	—	—	—
Revenue - First-Half Outlook	—	—	New“$1.73 billion to $1.89 billion”	—	—	—	—	—
Revenue - Full Year 2025 Outlook	—	—	New“$4.15 billion to $4.35 billion”	—	—	—	—	—
Revenue - Second-Half Outlook	—	—	New“$2.42 billion to $2.46 billion”	—	—	—	—	—
Revenue Excl. India	—	—	—	—	—	—	New“$850 million to $900 million”	—
Revenue excluding India	—	—	—	New“$1.24 billion to $1.34 billion”	Lowered“$1.12 billion to $1.22 billion”	—	—	—
Revenue excluding India	—	—	—	New“$1.00 billion to $1.10 billion”	—	—	—	—
Revenue expected range	—	—	New“$940 million to $1.10 billion”	—	—	—	—	—
Revenue growth at midpoint vs. 2024	—	—	—	—	New“(7)%”	—	—	—
Revenue growth at midpoint vs. 2024	—	—	—	—	New“(4)%”	—	—	—
Revenue growth at midpoint vs. 2024	—	New“-16%”	—	—	—	—	—	—
Revenue growth at midpoint vs. 2024 - Q2 2025	—	—	New“(2)%”	—	—	—	—	—
Revenue growth at midpoint vs. 2024 - Second-Half	—	—	New“7%”	—	—	—	—	—
Revenue outlook	—	—	—	New“$4.08 billion to $4.28 billion”	Lowered“$3.92 billion to $4.02 billion”	—	—	—
Adjusted earnings per diluted share	—	—	—	—	New“$1.14 to $1.36”	—	—	—
Adjusted earnings per diluted share	—	—	—	New“$0.78 to $0.98”	—	—	—	—
Adjusted earnings per diluted share	—	—	—	New“$1.62 to $1.84”	—	—	—	—
Adjusted earnings per diluted share	—	New“$3.26 to $3.70”	—	—	—	—	—	—
Adjusted earnings per diluted share expected range	—	—	New“$0.52 to $0.68”	—	—	—	—	—
Adjusted earnings per diluted share outlook	—	—	New“$3.26 to $3.70”	Reiterated“$3.26 to $3.70”	Lowered“$2.92 to $3.14”	—	—	—
Adjusted EBITDA	—	—	—	—	—	—	New“$130 million to $150 million”	—
Adjusted EBITDA	—	—	—	New“$334 million to $374 million”	Lowered“$265 million to $305 million”	—	—	—
Adjusted EBITDA	—	—	New“$575 million to $625 million”	—	Raised“$830 million to $870 million”	—	—	—
Adjusted EBITDA	—	—	—	New“$210 million to $250 million”	—	—	—	—
Adjusted EBITDA	—	—	—	New“$334 million to $374 million”	—	—	—	—
Adjusted EBITDA	—	—	—	New“$544 million to $624 million”	—	—	—	—
Adjusted EBITDA	—	—	New“$295 million to $325 million”	—	—	—	—	—
Adjusted EBITDA	—	New“$870 million to $950 million”	—	—	—	—	—	—
Adjusted EBITDA	—	New“$105 million to $125 million”	—	—	—	—	—	—
Adjusted EBITDA - First-Half Outlook	—	—	New“$295 million to $325 million”	—	—	—	—	—
Adjusted EBITDA - Full Year 2025 Outlook	—	—	New“$870 million to $950 million”	—	—	—	—	—
Adjusted EBITDA - Second-Half Outlook	—	—	New“$575 million to $625 million”	—	—	—	—	—
Adjusted EBITDA forecast	—	—	New“$175 million to $205 million”	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024	—	New“1%”	—	—	Lowered“(6)%”	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024	—	—	—	—	New“(16)%”	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024	—	New“-28%”	—	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024 - First-Half	—	—	New“(15)%”	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024 - Full Year 2025	—	—	New“1%”	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024 - Q2 2025	—	—	New“(6)%”	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2024 - Second-Half	—	—	New“11%”	—	—	—	—	—
Adjusted EBITDA outlook	—	—	—	New“$870 million to $950 million”	Lowered“$830 million to $870 million”	—	—	—
Adjusted EPS	—	—	—	New“$1.62 to $1.84”	Lowered“$1.14 to $1.36”	—	—	—
Adjusted EPS	—	—	—	New“$2.40 to $2.82”	—	—	—	—
Adjusted EPS	—	New“$0.05 to $0.15”	—	—	—	—	—	—
Adjusted EPS - First-Half Outlook	—	—	New“$0.70 to $0.86”	—	—	—	—	—
Adjusted EPS - Full Year 2025 Outlook	—	—	New“$3.26 to $3.70”	—	—	—	—	—
Adjusted EPS - Q2 2025 Outlook	—	—	New“$0.52 to $0.68”	—	—	—	—	—
Adjusted EPS - Second-Half Outlook	—	—	New“$2.56 to $2.84”	—	—	—	—	—
Adjusted EPS diluted shares assumption	—	New“125.6 million diluted shares for full year”	—	—	—	—	—	—
Adjusted EPS diluted shares assumption	—	New“125.6 million diluted shares for Q1”	—	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2024	—	New“0%”	—	—	Lowered“(13)%”	—	—	—
Adjusted EPS growth at midpoint vs. 2024	—	—	—	—	New“(30)%”	—	—	—
Adjusted EPS growth at midpoint vs. 2024	—	New“-72%”	—	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2024 - First-Half	—	—	New“(21)%”	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2024 - Full Year 2025	—	—	New“0%”	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2024 - Q2 2025	—	—	New“(5)%”	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2024 - Second-Half	—	—	New“9%”	—	—	—	—	—
Adjusted EPS^	—	—	—	—	—	—	New“$0.16 to $0.26”	—
Adjusted EPS^	—	—	New“$2.56 to $2.84”	—	Raised“$2.92 to $3.14”	—	—	—
Adjusted EPS^	—	New“$3.26 to $3.70”	—	Reiterated“$3.26 to $3.70”	—	—	—	—
Adjusted EPS^	—	—	New“$0.70 to $0.86”	—	—	—	—	—
EPS estimate diluted shares assumption - full year	—	—	New“125.6 million diluted shares”	—	—	—	—	—
EPS estimate diluted shares assumption - Q2	—	—	New“125.6 million diluted shares”	—	—	—	—	—
Estimated incremental tariff costs embedded in adjusted EBITDA	—	—	New“$15 million to $20 million”	—	—	—	—	—
FX headwind (on adjusted EBITDA)	—	New“$65 million to $75 million”	—	—	—	—	—	—
Lost EBITDA from GSS sale	—	New“approximately $25 million”	—	—	—	—	—	—
Second-half adjusted EBITDA increase implied by first-half midpoint	—	—	New“11 percent increase”	—	—	—	—	—
Second-half adjusted EPS increase implied by first-half midpoint	—	—	New“9 percent increase”	—	—	—	—	—
COGS tailwinds	—	New“$175 million to $200 million”	—	—	—	—	—	—
Free cash flow	—	New“$200 million to $400 million”	—	—	—	—	—	—
Free cash flow forecast	—	—	New“$200 million to $400 million”	Reiterated“$200 million to $400 million”	Lowered“negative $200 million to $0”	—	—	—
Growth at midpoint vs. 2024	—	—	New“11%”	—	Lowered“(13)%”	—	—	—
Growth at midpoint vs. 2024	—	—	—	New“(3)%”	Lowered“(16)%”	—	—	—
Growth at midpoint vs. 2024	—	—	—	New“(1)%”	—	—	—	—
Growth at midpoint vs. 2024	—	—	—	New“0%”	—	—	—	—
Growth at midpoint vs. 2024	—	—	New“(15)%”	—	—	—	—	—
Growth at midpoint vs. 2025*	—	—	—	—	—	—	New“(17)%”	—
Incremental tariff costs	—	—	New“$15 million to $20 million”	—	—	—	—	—
Lost sales from GSS divestiture	—	New“approximately $110 million”	—	—	—	—	—	—
Second-half sales increase implied by first-half midpoint	—	—	New“7 percent increase”	—	—	—	—	—
For FY2024
Revenue	New“$1.30 billion to $1.41 billion”	—	—	—	—	—	—	—
Revenue growth at midpoint vs. 2023	New“-2%”	—	—	—	—	—	—	—
Revenue growth at midpoint vs. 2023	New“19%”	—	—	—	—	—	—	—
Revenue outlook	New“$4.33 billion to $4.44 billion”	—	—	—	—	—	—	—
Adjusted earnings per diluted share	New“$1.47 to $1.83”	—	—	—	—	—	—	—
Adjusted earnings per diluted share outlook range	New“$3.16 to $3.52”	—	—	—	—	—	—	—
Adjusted EBITDA	New“$321 million to $351 million”	—	—	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2023	New“-8%”	—	—	—	—	—	—	—
Adjusted EBITDA growth at midpoint vs. 2023	New“32%”	—	—	—	—	—	—	—
Adjusted EBITDA outlook range	New“$885 million to $915 million”	—	—	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2023	New“-12%”	—	—	—	—	—	—	—
Adjusted EPS growth at midpoint vs. 2023	New“54%”	—	—	—	—	—	—	—
Adjusted EPS^	New“$3.16 to $3.52”	—	—	—	—	—	—	—
Adjusted EPS^	New“$1.47 to $1.83”	—	—	—	—	—	—	—
Free cash flow outlook range	New“$400 million to $500 million”	—	—	—	—	—	—	—
Target restructuring savings range	New“$125 million to $150 million of adjusted EBITDA net benefit”	—	—	—	—	—	—	—
Tax rate range	New“13 to 15 percent”	—	—	—	—	—	—	—
No period stated
Adjusted EPS diluted shares assumption	—	—	—	—	—	New“125.7 million diluted shares for full year and 125.7 million diluted shares for Q1”	—	—
Target restructuring savings range (adjusted EBITDA net benefit)	New“$125 million to $150 million”	—	—	—	—	—	—	—
Proceeds to be used for debt paydown	—	—	—	—	—	—	—	New“approximately $1 billion”
Quarterly dividend	—	—	—	—	New“$0.08 per share”	—	—	—

Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.